Sven-Ove Ögren mainly investigates Internal medicine, Endocrinology, Dopamine, Pharmacology and Dopamine receptor D2. His Internal medicine study frequently links to other fields, such as Neuroscience. His Endocrinology study incorporates themes from Neuropeptide and Monoamine neurotransmitter, Serotonin.
His work in the fields of Dopamine, such as Dopaminergic, Dopamine receptor, Dopamine receptor D1 and Raclopride, intersects with other areas such as Offspring. The concepts of his Dopaminergic study are interwoven with issues in Neurturin, GDNF family of ligands and Anatomy. The various areas that Sven-Ove Ögren examines in his Pharmacology study include Striatum, Receptor, Postsynaptic potential, Zimelidine and Antidepressant.
Sven-Ove Ögren mostly deals with Endocrinology, Internal medicine, Pharmacology, Neuroscience and Dopamine. The Endocrinology study combines topics in areas such as Agonist, Neuropeptide, Receptor, Galanin and Serotonin. His Receptor study combines topics in areas such as Cerebral cortex and Binding site.
Sven-Ove Ögren focuses mostly in the field of Internal medicine, narrowing it down to matters related to Desipramine and, in some cases, Neurotoxin. His research in Pharmacology focuses on subjects like Antidepressant, which are connected to Mechanism of action. His Dopamine receptor D2 research integrates issues from Dopaminergic and Catalepsy.
His primary areas of study are Internal medicine, Endocrinology, Pharmacology, Neuroscience and Galanin. His study in the field of Muscarinic acetylcholine receptor, Microdialysis, 5-HT receptor and Agonist also crosses realms of Behavioural analysis. His research integrates issues of AMPA receptor and Neuroprotection in his study of Endocrinology.
The study incorporates disciplines such as Dopamine receptor D2, Dopamine, Male mice and Antagonism in addition to Pharmacology. His work investigates the relationship between Dopamine receptor D2 and topics such as Dopaminergic that intersect with problems in Tyrosine hydroxylase. He interconnects Hippocampus, Acetylcholine and Cholinergic in the investigation of issues within Galanin.
Sven-Ove Ögren focuses on Pharmacology, Endocrinology, Internal medicine, Dopamine and Neuroscience. His Pharmacology research is multidisciplinary, relying on both Male mice, Dopamine β hydroxylase, Anxiolytic and Zimelidine. His Endocrinology research is multidisciplinary, incorporating perspectives in Agonist and Galanin, Galanin receptor 2.
His research investigates the connection between Galanin and topics such as Microdialysis that intersect with issues in Acetylcholine and 5-HT receptor. His research in the fields of Dopaminergic and Dopamine receptor D2 overlaps with other disciplines such as Chlorphentermine. His studies deal with areas such as Antidepressant, 5-HT2A receptor, 5-HT6 receptor and Serotonergic as well as Dopamine receptor D2.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
A. Tomac;E. Lindqvist;L.-F. H. Lin;S. O. Ögren.
Specific in vitro and in vivo binding of 3H-raclopride a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain
Christer Köhler;Håkan Hall;Sven-Ove Ögren;Lars Gawell.
Biochemical Pharmacology (1985)
The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
S O Ogren;H Hall;C Köhler;O Magnusson.
Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brain
S.O. Ögren;H. Hall;C. Köhler;O. Magnusson.
European Journal of Pharmacology (1984)
Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs.
S. O. Ögren;K. Fuxe;L. F. Agnati;J. Å. Gustafssons.
Journal of Neural Transmission (1979)
Acquisition, Expression, and Reinstatement of Ethanol-Induced Conditioned Place Preference in Mice: Effects of Opioid Receptor-Like 1 Receptor Agonists and Naloxone
A. Kuzmin;J. Sandin;L. Terenius;S. O. Ögren.
Journal of Pharmacology and Experimental Therapeutics (2003)
Chronic antidepressant treatment and central 5-HT synapses
K. Fuxe;S.-O. Ögren;L.F. Agnati;F. Benfenati.
Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey.
Erling Ehrin;Lars Farde;Tomas de Paulis;Lars Eriksson.
The International Journal of Applied Radiation and Isotopes (1985)
On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine.
Fuxe K;Farnebo Lo;Hamberger B;Ogren So.
Postgraduate Medical Journal (1975)
Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat
S.O Ögren;A Pramanik;P.A Schött.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: